WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010027340) PHARMACEUTICAL COMPOSITIONS COMPOSING ENTAKAPON, LEVODOPA AND KARBIDOBA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/027340    International Application No.:    PCT/TR2009/000112
Publication Date: 11.03.2010 International Filing Date: 03.09.2009
IPC:
A61K 9/16 (2006.01), A61K 31/195 (2006.01), A61K 31/198 (2006.01), A61K 31/275 (2006.01), A61K 47/26 (2006.01)
Applicants: DR. F. FRIK ILAC SANAYI VE TICARET ANONIM SIRKETI [TR/TR]; Aydinevler Mahallesi Sanayi Caddesi No: 42 34854 Kucukyali Maltepe Istanbul (TR) (For All Designated States Except US).
SIRIN, Ebrahimi [TR/TR]; (TR) (For US Only).
GULHAN, Badem [TR/TR]; (TR) (For US Only).
MEHMET, Agcayazi [TR/TR]; (TR) (For US Only)
Inventors: SIRIN, Ebrahimi; (TR).
GULHAN, Badem; (TR).
MEHMET, Agcayazi; (TR)
Agent: BASALAN PATENT & TRADE MARK INDUSTRIAL PROPERTY SERVICES CONSULTANCY LIMITED COMPANY; Giz 2000 Plaza Ayazaga Yolu No.7 / Kat: 12 34398 Maslak Istanbul (TR)
Priority Data:
2008/06646 03.09.2008 TR
Title (EN) PHARMACEUTICAL COMPOSITIONS COMPOSING ENTAKAPON, LEVODOPA AND KARBIDOBA
(FR) COMPOSITIONS PHARMACEUTIQUES D'ENTACAPONE, DE LEVODOPA ET DE CARBIDOBA
Abstract: front page image
(EN)Present invention is related with pharmaceutical compositions consisting of entakapan, levodapa, and karbidopa characterized in that it contains pharmaceutically stable compositions used for Parkinson disease in which comprising entakapan, levodapa, and karbidopa or pharmaceutically acceptable salts, aqueous forms of these molecules or any kind of physicochemical polymorphs thereof and the preparation of these compositions.
(FR)L'invention concerne des compositions pharmaceutiques stables d'entacapone, de levodopa et de carbidoba utilisées pour le traitement de la maladie de Parkinson. Lesdites compositions contiennent de l'entacapone, du levodopa et du carbidoba ou leurs sels pharmaceutiquement acceptables, des formes aqueuses de ces molécules, ainsi que toute forme de leurs polymorphes physicochimiques. L'invention concerne également la préparation de ces compositions.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)